Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michael Marks
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
83
Collins, Allan
29
Grady, Sharon
24
Whiteaker, Paul
15
McIntosh, Michael
13
Stitzel, Jerry
9
Picciotto, Marina
9
Pauly, James
8
Lester, Henry
7
Salminen, Outi
6
Labarca, Cesar
6
Changeux, Jean-Pierre
5
Deshpande, Purnima
5
McCallum, Sarah
5
McKinney, Sheri
4
Nashmi, Raad
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michael Marks (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Marks Michael J; Wageman Charles R; Grady Sharon R; Gopalakrishnan Murali; Briggs Clark A
Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.
Biochemical pharmacology 2009;78(7):795-802.
-
2009: Mineur Y S; Brunzell D H; Grady S R; Lindstrom J M; McIntosh J M; Marks M J; King S L; Picciotto M R
Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning.
Genes, brain, and behavior 2009;8(3):257-66.
-
2009: Grady Sharon R; Moretti Milena; Zoli Michele; Marks Michael J; Zanardi Alessio; Pucci Luca; Clementi Francesco; Gotti Cecilia
Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(7):2272-82.
-
2009: Collins Allan C; Salminen Outi; Marks Michael J; Whiteaker Paul; Grady Sharon R
The road to discovery of neuronal nicotinic cholinergic receptor subtypes.
Handbook of experimental pharmacology 2009;(192):85-112.
-
2008: Drenan Ryan M; Grady Sharon R; Whiteaker Paul; McClure-Begley Tristan; McKinney Sheri; Miwa Julie M; Bupp Sujata; Heintz Nathaniel; McIntosh J Michael; Bencherif Merouane; Marks Michael J; Lester Henry A
In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors.
Neuron 2008;60(1):123-36.
-
2008: Gotti Cecilia; Moretti Milena; Meinerz Natalie M; Clementi Francesco; Gaimarri Annalisa; Collins Allan C; Marks Michael J
Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
Molecular pharmacology 2008;73(6):1796-807.
-
2007: Tapper Andrew R; McKinney Sheri L; Marks Michael J; Lester Henry A
Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice.
Physiological genomics 2007;31(3):422-8.
-
2007: Grady Sharon R; Salminen Outi; Laverty Duncan C; Whiteaker Paul; McIntosh J Michael; Collins Allan C; Marks Michael J
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.
Biochemical pharmacology 2007;74(8):1235-46.
-
2007: Teper Yaroslav; Whyte Douglas; Cahir Elizabeth; Lester Henry A; Grady Sharon R; Marks Michael J; Cohen Bruce N; Fonck Carlos; McClure-Begley Tristan; McIntosh J Michael; Labarca Cesar; Lawrence Andrew; Chen Feng; Gantois Ilse; Davies Philip J; Petrou Steven; Murphy Mark; Waddington John; Horne Malcolm K; Berkovic Samuel F; Drago John
Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(38):10128-42.
-
2007: Marks Michael J; Meinerz Natalie M; Drago John; Collins Allan C
Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Neuropharmacology 2007;53(3):390-405.
-
2007: Nashmi Raad; Xiao Cheng; Deshpande Purnima; McKinney Sheri; Grady Sharon R; Whiteaker Paul; Huang Qi; McClure-Begley Tristan; Lindstrom Jon M; Labarca Cesar; Collins Allan C; Marks Michael J; Lester Henry A
Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(31):8202-18.
-
2007: Damaj M I; Fonck C; Marks M J; Deshpande P; Labarca C; Lester H A; Collins A C; Martin B R
Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.
The Journal of pharmacology and experimental therapeutics 2007;321(3):1161-9.
-
2007: Salminen Outi; Drapeau Jennifer A; McIntosh J Michael; Collins Allan C; Marks Michael J; Grady Sharon R
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.
Molecular pharmacology 2007;71(6):1563-71.
-
2007: Matta Shannon G; Balfour David J; Benowitz Neal L; Boyd R Thomas; Buccafusco Jerry J; Caggiula Anthony R; Craig Caroline R; Collins Allan C; Damaj M Imad; Donny Eric C; Gardiner Phillip S; Grady Sharon R; Heberlein Ulrike; Leonard Sherry S; Levin Edward D; Lukas Ronald J; Markou Athina; Marks Michael J; McCallum Sarah E; Parameswaran Neeraja; Perkins Kenneth A; Picciotto Marina R; Quik Maryka; Rose Jed E; Rothenfluh Adrian; Schafer William R; Stolerman Ian P; Tyndale Rachel F; Wehner Jeanne M; Zirger Jeffrey M
Guidelines on nicotine dose selection for in vivo research.
Psychopharmacology 2007;190(3):269-319.
-
2006: Whiteaker Paul; Cooper John F; Salminen Outi; Marks Michael J; McClure-Begley Tristan D; Brown Robert W B; Collins Allan C; Lindstrom Jon M
Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression.
The Journal of comparative neurology 2006;499(6):1016-38.
-
2006: Marks Michael J; Whiteaker Paul; Collins Allan C
Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
Molecular pharmacology 2006;70(3):947-59.
-
2006: McCallum Sarah E; Collins Allan C; Paylor Richard; Marks Michael J
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.
Psychopharmacology 2006;184(3-4):314-27.
-
2005: Fonck Carlos; Cohen Bruce N; Nashmi Raad; Whiteaker Paul; Wagenaar Daniel A; Rodrigues-Pinguet Nivalda; Deshpande Purnima; McKinney Sheri; Kwoh Steven; Munoz Jose; Labarca Cesar; Collins Allan C; Marks Michael J; Lester Henry A
Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(49):11396-411.
-
2005: Gotti Cecilia; Moretti Milena; Zanardi Alessio; Gaimarri Annalisa; Champtiaux Nicolas; Changeux Jean-Pierre; Whiteaker Paul; Marks Michael J; Clementi Francesco; Zoli Michele
Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents.
Molecular pharmacology 2005;68(4):1162-71.
-
2005: Gotti Cecilia; Moretti Milena; Clementi Francesco; Riganti Loredana; McIntosh J Michael; Collins Allan C; Marks Michael J; Whiteaker Paul
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
Molecular pharmacology 2005;67(6):2007-15.
-
2005: Salminen Outi; Whiteaker Paul; Grady Sharon R; Collins Allan C; McIntosh J Michael; Marks Michael J
The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
Neuropharmacology 2005;48(5):696-705.
-
2004: Tapper Andrew R; McKinney Sheri L; Nashmi Raad; Schwarz Johannes; Deshpande Purnima; Labarca Cesar; Whiteaker Paul; Marks Michael J; Collins Allan C; Lester Henry A
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
Science (New York, N.Y.) 2004;306(5698):1029-32.
-
2004: Salminen Outi; Murphy Karen L; McIntosh J Michael; Drago John; Marks Michael J; Collins Allan C; Grady Sharon R
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
Molecular pharmacology 2004;65(6):1526-35.
-
2004: Marks Michael J; Rowell Peter P; Cao Jian-Zhe; Grady Sharon R; McCallum Sarah E; Collins Allan C
Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.
Neuropharmacology 2004;46(8):1141-57.
-
2004: McIntosh J Michael; Azam Layla; Staheli Sarah; Dowell Cheryl; Lindstrom Jon M; Kuryatov Alexander; Garrett James E; Marks Michael J; Whiteaker Paul
Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
Molecular pharmacology 2004;65(4):944-52.
-
2004: Tritto Theresa; McCallum Sarah E; Waddle Satori A; Hutton Scott R; Paylor Richard; Collins Allan C; Marks Michael J
Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2004;6(1):145-58.
-
2003: Cui Changhai; Booker T K; Allen Roberta S; Grady Sharon R; Whiteaker Paul; Marks Michael J; Salminen Outi; Tritto Theresa; Butt Christopher M; Allen W R; Stitzel Jerry A; McIntosh J Michael; Boulter Jim; Collins Allan C; Heinemann Stephen F
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(35):11045-53.
-
2003: Quik Maryka; Bordia Tanuja; Okihara Michaella; Fan Hong; Marks Michael J; McIntosh J Michael; Whiteaker Paul
L-DOPA treatment modulates nicotinic receptors in monkey striatum.
Molecular pharmacology 2003;64(3):619-28.
-
2003: King Sarah L; Marks Michael J; Grady Sharon R; Caldarone Barbara J; Koren Andrei O; Mukhin Alexey G; Collins Allan C; Picciotto Marina R
Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(9):3837-43.
-
2003: Quik Maryka; Sum Jocelyn D; Whiteaker Paul; McCallum Sarah E; Marks Michael J; Musachio John; McIntosh J Michael; Collins Allan C; Grady Sharon R
Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
Molecular pharmacology 2003;63(5):1169-79.
-
2003: Fonck Carlos; Nashmi Raad; Deshpande Purnima; Damaj M Imad; Marks Michael J; Riedel Anett; Schwarz Johannes; Collins Allan C; Labarca Cesar; Lester Henry A
Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(7):2582-90.
-
2002: Butt Christopher M; Hutton Scott R; Marks Michael J; Collins Allan C
Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes.
Journal of neurochemistry 2002;83(1):48-56.
-
2002: Dobelis Peter; Marks Michael J; Whiteaker Paul; Balogh Seth A; Collins Allan C; Stitzel Jerry A
A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function.
Molecular pharmacology 2002;62(2):334-42.
-
2002: Marks Michael J; Whiteaker Paul; Grady Sharon R; Picciotto Marina R; McIntosh J Michael; Collins Allan C
Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
Journal of neurochemistry 2002;81(5):1102-15.
-
2002: Grady Sharon R; Murphy Karen L; Cao Jian; Marks Michael J; McIntosh J Michael; Collins Allan C
Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.
The Journal of pharmacology and experimental therapeutics 2002;301(2):651-60.
-
2002: Tritto Theresa; Stitzel Jerry A; Marks Michael J; Romm Elena; Collins Allan C
Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes.
Pharmacogenetics 2002;12(3):197-208.
-
2002: Whiteaker Paul; Peterson Cyrus G; Xu Wei; McIntosh J Michael; Paylor Richard; Beaudet Arthur L; Collins Allan C; Marks Michael J
Involvement of the alpha3 subunit in central nicotinic binding populations.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(7):2522-9.
-
2002: Dukat Malgorzata; Damaj Imad M; Young Richard; Vann Robert; Collins Allan C; Marks Michael J; Martin Billy R; Glennon Richard A
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.
European journal of pharmacology 2002;435(2-3):171-80.
-
2001: Grady S R; Meinerz N M; Cao J; Reynolds A M; Picciotto M R; Changeux J P; McIntosh J M; Marks M J; Collins A C
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.
Journal of neurochemistry 2001;76(1):258-68.
-
2000: Marks M J; Stitzel J A; Grady S R; Picciotto M R; Changeux J P; Collins A C
Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype.
Neuropharmacology 2000;39(13):2632-45.
-
2000: Whiteaker P; Jimenez M; McIntosh J M; Collins A C; Marks M J
Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
British journal of pharmacology 2000;131(4):729-39.
-
2000: Whiteaker P; McIntosh J M; Luo S; Collins A C; Marks M J
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
Molecular pharmacology 2000;57(5):913-25.
-
2000: Sharples C G; Kaiser S; Soliakov L; Marks M J; Collins A C; Washburn M; Wright E; Spencer J A; Gallagher T; Whiteaker P; Wonnacott S
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(8):2783-91.
-
2000: Stitzel J A; Jimenez M; Marks M J; Tritto T; Collins A C
Potential role of the alpha4 and alpha6 nicotinic receptor subunits in regulating nicotine-induced seizures.
The Journal of pharmacology and experimental therapeutics 2000;293(1):67-74.
-
2000: Whiteaker P; Marks M J; Grady S R; Lu Y; Picciotto M R; Changeux J P; Collins A C
Pharmacological and null mutation approaches reveal nicotinic receptor diversity.
European journal of pharmacology 2000;393(1-3):123-35.
-
1999: Lu Y; Marks M J; Collins A C
Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1127-34.
-
1999: Whiteaker P; Davies A R; Marks M J; Blagbrough I S; Potter B V; Wolstenholme A J; Collins A C; Wonnacott S
An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain.
The European journal of neuroscience 1999;11(8):2689-96.
-
1999: Marks M J; Whiteaker P; Calcaterra J; Stitzel J A; Bullock A E; Grady S R; Picciotto M R; Changeux J P; Collins A C
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.
The Journal of pharmacology and experimental therapeutics 1999;289(2):1090-103.
-
1998: Lu Y; Grady S; Marks M J; Picciotto M; Changeux J P; Collins A C
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1998;287(2):648-57.
-
1998: Marks M J; Smith K W; Collins A C
Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
The Journal of pharmacology and experimental therapeutics 1998;285(1):377-86.
-
1997: Damaj M I; Glassco W; Marks M J; Slobe B; James J R; May E L; Rosecrans J A; Collins A C; Martin B R
Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.
The Journal of pharmacology and experimental therapeutics 1997;282(3):1425-34.
-
1997: Grady S R; Grun E U; Marks M J; Collins A C
Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment.
The Journal of pharmacology and experimental therapeutics 1997;282(1):32-43.
-
1997: Bullock A E; Clark A L; Grady S R; Robinson S F; Slobe B S; Marks M J; Collins A C
Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes.
Journal of neurochemistry 1997;68(6):2412-23.
-
1996: Marks M J; Pauly J R; Grun E U; Collins A C
ST/b and DBA/2 mice differ in brain alpha-bungarotoxin binding and alpha 7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis.
Brain research. Molecular brain research 1996;39(1-2):207-22.
-
1996: Pauly J R; Marks M J; Robinson S F; van de Kamp J L; Collins A C
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
The Journal of pharmacology and experimental therapeutics 1996;278(1):361-9.
-
1996: Marks M J; Robinson S F; Collins A C
Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1383-96.
-
1996: Robinson S F; Marks M J; Collins A C
Inbred mouse strains vary in oral self-selection of nicotine.
Psychopharmacology 1996;124(4):332-9.
-
1995: Marks M J; Bullock A E; Collins A C
Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1995;274(2):833-41.
-
1994: Marks M J; Grady S R; Yang J M; Lippiello P M; Collins A C
Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.
Journal of neurochemistry 1994;63(6):2125-35.
-
1994: Smolen A; Marks M J; DeFries J C; Henderson N D
Individual differences in sensitivity to nicotine in mice: response to six generations of selective breeding.
Pharmacology, biochemistry, and behavior 1994;49(3):531-40.
-
1994: Collins A C; Luo Y; Selvaag S; Marks M J
Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.
The Journal of pharmacology and experimental therapeutics 1994;271(1):125-33.
-
1994: Robinson S F; Pauly J R; Marks M J; Collins A C
An analysis of response to nicotine infusion using an automated radiotelemetry system.
Psychopharmacology 1994;115(1-2):115-20.
-
1994: Grady S R; Marks M J; Collins A C
Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.
Journal of neurochemistry 1994;62(4):1390-8.
-
1994: Luo Y; Marks M J; Collins A C
Genotype regulates the development of tolerance to ethanol and cross-tolerance to nicotine.
Alcohol (Fayetteville, N.Y.) 1994;11(2):167-76.
-
1994: Bhat R V; Marks M J; Collins A C
Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding.
Journal of neurochemistry 1994;62(2):574-81.
-
1993: Collins A C; Romm E; Selvaag S; Turner S; Marks M J
A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1390-7.
-
1993: Marks M J; Grady S R; Collins A C
Downregulation of nicotinic receptor function after chronic nicotine infusion.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1268-76.
-
1993: Marks M J; Farnham D A; Grady S R; Collins A C
Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1993;264(2):542-52.
-
1992: Grady S; Marks M J; Wonnacott S; Collins A C
Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.
Journal of neurochemistry 1992;59(3):848-56.
-
1992: Marks M J; Pauly J R; Gross S D; Deneris E S; Hermans-Borgmeyer I; Heinemann S F; Collins A C
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(7):2765-84.
-
1991: Marks M J; Campbell S M; Romm E; Collins A C
Genotype influences the development of tolerance to nicotine in the mouse.
The Journal of pharmacology and experimental therapeutics 1991;259(1):392-402.
-
1991: Pauly J R; Marks M J; Gross S D; Collins A C
An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment.
The Journal of pharmacology and experimental therapeutics 1991;258(3):1127-36.
-
1991: Bhat R V; Turner S L; Selvaag S R; Marks M J; Collins A C
Regulation of brain nicotinic receptors by chronic agonist infusion.
Journal of neurochemistry 1991;56(6):1932-9.
-
1990: Bhat R V; Turner S L; Marks M J; Collins A C
Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
The Journal of pharmacology and experimental therapeutics 1990;255(1):187-96.
-
1990: Collins A C; Campbell S M; Romm E; Marks M J
A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice.
Alcoholism, clinical and experimental research 1990;14(4):605-15.
-
1990: de Fiebre C M; Marks M J; Collins A C
Ethanol-nicotine interactions in long-sleep and short-sleep mice.
Alcohol (Fayetteville, N.Y.) 1990;7(3):249-57.
-
1990: Romm E; Lippiello P M; Marks M J; Collins A C
Purification of L-[3H]nicotine eliminates low affinity binding.
Life sciences 1990;46(13):935-43.
-
1990: Fiedler E P; Marks M J; Collins A C
Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1990;8(5):533-40.
-
1990: Collins A C; Bhat R V; Pauly J R; Marks M J
Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists.
Ciba Foundation symposium 1990;152():68-82; discussion 82-6.
-
1989: Marks M J; Romm E; Campbell S M; Collins A C
Variation of nicotinic binding sites among inbred strains.
Pharmacology, biochemistry, and behavior 1989;33(3):679-89.
-
1989: Marks M J; Stitzel J A; Collins A C
Genetic influences on nicotine responses.
Pharmacology, biochemistry, and behavior 1989;33(3):667-78.
-
1989: Pauly J R; Stitzel J A; Marks M J; Collins A C
An autoradiographic analysis of cholinergic receptors in mouse brain.
Brain research bulletin 1989;22(2):453-9.
-
1989: Collins A C; Marks M J; Pauly J R
Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice.
Journal of substance abuse 1989;1(3):273-86.
-
1989: Collins A C; Marks M J; Pauly J R
Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice.
Journal of substance abuse 1989;1(3):273-86.
-
1988: Collins A C; Miner L L; Marks M J
Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse.
Pharmacology, biochemistry, and behavior 1988;30(1):269-78.
-
1988: Stitzel J A; Campbell S M; Collins A C; Marks M J
Sulfhydryl modification of two nicotinic binding sites in mouse brain.
Journal of neurochemistry 1988;50(3):920-8.
-
1988: Collins A C; Burch J B; de Fiebre C M; Marks M J
Tolerance to and cross tolerance between ethanol and nicotine.
Pharmacology, biochemistry, and behavior 1988;29(2):365-73.
-
1988: Burch J B; de Fiebre C M; Marks M J; Collins A C
Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.
Psychopharmacology 1988;95(4):452-8.
-
1987: Marks M J; Romm E; Collins A C
Mouse brain ATPase activities after chronic nicotine infusion.
Biochemical pharmacology 1987;36(19):3318-20.
-
1987: Marks M J; Romm E; Collins A C
Genetic influences on tolerance development with chronic oxotremorine infusion.
Pharmacology, biochemistry, and behavior 1987;27(4):723-32.
-
1987: Marks M J; Stitzel J A; Collins A C
Influence of kinetics of nicotine administration on tolerance development and receptor levels.
Pharmacology, biochemistry, and behavior 1987;27(3):505-12.
-
1986: Marks M J; Stitzel J A; Collins A C
Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
The Journal of pharmacology and experimental therapeutics 1986;239(2):358-64.
-
1986: Marks M J; Stitzel J A; Romm E; Wehner J M; Collins A C
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
Molecular pharmacology 1986;30(5):427-36.
-
1986: Marks M J; Romm E; Gaffney D K; Collins A C
Nicotine-induced tolerance and receptor changes in four mouse strains.
The Journal of pharmacology and experimental therapeutics 1986;237(3):809-19.
-
1985: Marks M J; Stitzel J A; Collins A C
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
The Journal of pharmacology and experimental therapeutics 1985;235(3):619-28.
-
1985: Marks M J; Romm E; Bealer S M; Collins A C
A test battery for measuring nicotine effects in mice.
Pharmacology, biochemistry, and behavior 1985;23(2):325-30.
-
1984: Collins A C; Smolen A; Wayman A L; Marks M J
Ethanol and temperature effects on five membrane bound enzymes.
Alcohol (Fayetteville, N.Y.) 1984;1(3):237-46.
Sign-in to see more
